Drug ID:   | NPD1691 |
Drug Name:   | |
Molecular Formula:   | C15H18N6O |
Canonical SMILES:   | N#Cc1ccc(=NCCNCC(=O)N2CCC[C@H]2C#N)[nH]c1 |
Standard InCHI:   | InChI=1S/C15H18N6O/c16-8-12-3-4-14(20-10-12)19-6-5-18-11-15(22)21-7-1-2-13(21)9-17/h3-4,10,13,18H,1-2,5-7,11H2,(H,19,20)/t13-/m0/s1 |
Standard InCHIKey:   | VFFZWMWTUSXDCB-ZDUSSCGKSA-N |
Max Developmental Stage:   | Clinical (unspecified phase) |
Max Developmental Stage Source:   | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
Similarity Level | Similarity Score | Natural Product ID |
---|---|---|
Remote Similarity | 0.5979 | NPC25513 |
Remote Similarity | 0.587 | NPC76869 |
Remote Similarity | 0.587 | NPC477460 |
Remote Similarity | 0.57 | NPC132858 |
Remote Similarity | 0.57 | NPC267203 |
Remote Similarity | 0.57 | NPC77890 |
Remote Similarity | 0.5619 | NPC476141 |
Molecular Weight   | 298.15 |
ALogP   | -2.4744 |
MLogP   | 2.34 |
XLogP   | -0.593 |
HDA   | 7 |
HBD   | 2 |
Rotatable Bonds   | 6 |
TPSA   | 104.31 |
RO5 Violation   | 0 |